Company news

NeoGenomics, Inc. news in 2020

NeoGenomics, Inc.'s news releases, calls and decks from 2020, newest first.

View company

NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020

November 12, 2020

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

November 8, 2020

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

October 26, 2020

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

October 12, 2020

NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

September 30, 2020

NeoGenomics To Virtually Participate In Fireside Chat At The 18th Annual Morgan Stanley Global Healthcare Conference

September 9, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

July 27, 2020

NeoGenomics Announces Board Appointments

July 19, 2020

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

June 30, 2020

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

June 28, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

June 1, 2020

NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference

May 31, 2020

NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference

May 25, 2020

NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test

May 25, 2020

NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference

May 10, 2020

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

May 4, 2020

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

April 27, 2020

NeoGenomics Provides COVID-19 Business Update

April 8, 2020

NeoGenomics Integrates HALO(R) From Indica Labs

April 2, 2020

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

March 31, 2020

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

March 1, 2020

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

February 27, 2020

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter

February 26, 2020

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020

February 5, 2020

NeoGenomics Announces Leadership Appointments

February 4, 2020

NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million

January 9, 2020

Decks in 2020